These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 36358480)

  • 21. Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney.
    Tain YL; Joles JA
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal High-Fat Diet and Offspring Hypertension.
    Tain YL; Hsu CN
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?
    Tain YL; Hsu CN
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin.
    Tain YL; Hsu CN
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.
    Ilkun O; Boudina S
    Curr Pharm Des; 2013; 19(27):4806-17. PubMed ID: 23323621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical basis for pharmacological intervention as a reprogramming strategy against hypertension and kidney disease of developmental origin.
    Tain YL; Chan SHH; Chan JYH
    Biochem Pharmacol; 2018 Jul; 153():82-90. PubMed ID: 29309755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming.
    Tain YL; Hsu CN
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease.
    Hsu CN; Tain YL
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal Oxidative Stress and Kidney Health: Bridging the Gap between Animal Models and Clinical Reality.
    Tain YL; Hsu CN
    Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perinatal Use of Melatonin for Offspring Health: Focus on Cardiovascular and Neurological Diseases.
    Hsu CN; Huang LT; Tain YL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation, oxidative stress and metabolic syndrome: dietary modulation.
    Fernández-García JC; Cardona F; Tinahones FJ
    Curr Vasc Pharmacol; 2013 Nov; 11(6):906-19. PubMed ID: 24168441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease.
    Hsu CN; Tain YL
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31010060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Arginine Nutrition and Metabolism during Pregnancy on Offspring Outcomes.
    Hsu CN; Tain YL
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31252534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinated Contribution of NADPH Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Metabolic Syndrome and Its Implication in Renal Dysfunction.
    Lee H; Jose PA
    Front Pharmacol; 2021; 12():670076. PubMed ID: 34017260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension of Developmental Origins: Consideration of Gut Microbiome in Animal Models.
    Tain YL; Hsu CN
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.
    Hsu CN; Hou CY; Tain YL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.
    Hsu CN; Tain YL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol.
    Feillet-Coudray C; Fouret G; Ebabe Elle R; Rieusset J; Bonafos B; Chabi B; Crouzier D; Zarkovic K; Zarkovic N; Ramos J; Badia E; Murphy MP; Cristol JP; Coudray C
    Free Radic Res; 2014 Oct; 48(10):1232-46. PubMed ID: 25066801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The developmental origins, mechanisms, and implications of metabolic syndrome.
    Bruce KD; Hanson MA
    J Nutr; 2010 Mar; 140(3):648-52. PubMed ID: 20107145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.